Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform

被引：0
|
作者：
Francisco Martínez-Dubarbie
Armando Guerra-Ruiz
Sara López-García
Carmen Lage
Marta Fernández-Matarrubia
Jon Infante
Ana Pozueta-Cantudo
María García-Martínez
Andrea Corrales-Pardo
María Bravo
Marcos López-Hoyos
Juan Irure-Ventura
Pascual Sánchez-Juan
María Teresa García-Unzueta
Eloy Rodríguez-Rodríguez
机构：
[1] Neurology Service,Biochemistry and Clinical Analysis Department
[2] Marqués de Valdecilla University Hospital,Atlantic Fellow for Equity in Brain Health
[3] Institute for Research Marqués de Valdecilla (IDIVAL),CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases
[4] Marqués de Valdecilla University Hospital,Medicine and Psychiatry Department
[5] Global Brain Health Institute,Immunology Department
[6] University of California,Molecular Biology Department
[7] National Institute of Health Carlos III,undefined
[8] University of Cantabria,undefined
[9] Universidad Europea del Atlántico,undefined
[10] Marqués de Valdecilla University Hospital,undefined
[11] University of Cantabria,undefined
[12] CIEN Foundation/Queen Sofia Foundation Alzheimer Center,undefined
来源：
Alzheimer's Research & Therapy | / 15卷
关键词：
Alzheimer’s disease; Plasma biomarkers; Early diagnosis; Screening; Validation; Lumipulse;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 20 条
  • [1] Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer's pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform
    Martinez-Dubarbie, Francisco
    Guerra-Ruiz, Armando
    Lopez-Garcia, Sara
    Lage, Carmen
    Fernandez-Matarrubia, Marta
    Infante, Jon
    Pozueta-Cantudo, Ana
    Garcia-Martinez, Maria
    Corrales-Pardo, Andrea
    Bravo, Maria
    Lopez-Hoyos, Marcos
    Irure-Ventura, Juan
    Sanchez-Juan, Pascual
    Garcia-Unzueta, Maria Teresa
    Rodriguez-Rodriguez, Eloy
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [2] Influence of Physiological Variables and Comorbidities on Plasma Aβ40, Aβ42, and p-tau181 Levels in Cognitively Unimpaired Individuals
    Martinez-Dubarbie, Francisco
    Guerra-Ruiz, Armando
    Lopez-Garcia, Sara
    Irure-Ventura, Juan
    Lage, Carmen
    Fernandez-Matarrubia, Marta
    Pozueta-Cantudo, Ana
    Garcia-Martinez, Maria
    Corrales-Pardo, Andrea
    Bravo, Maria
    Martin-Arroyo, Juan
    Infante, Jon
    Lopez-Hoyos, Marcos
    Garcia-Unzueta, Maria Teresa
    Sanchez-Juan, Pascual
    Rodriguez-Rodriguez, Eloy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [3] Diagnostic Accuracy of Plasma p-tau217 for Detecting Pathological Cerebrospinal Fluid Changes in Cognitively Unimpaired Subjects Using the Lumipulse Platform
    Martinez-Dubarbie, Francisco
    Guerra-Ruiz, A.
    Lopez-Garcia, S.
    Lage, C.
    Fernandez-Matarrubia, M.
    Infante, J.
    Pozueta-Cantudo, A.
    Garcia-Martinez, M.
    Corrales-Pardo, A.
    Bravo, M.
    Lopez-Hoyos, M.
    Irure-Ventura, J.
    Valeriano-Lorenzo, E.
    Garcia-Unzueta, M. T.
    Sanchez-Juan, P.
    Rodriguez-Rodriguez, E.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (06): : 1581 - 1591
  • [4] Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA
    Quaresima, Virginia
    Pilotto, Andrea
    Trasciatti, Chiara
    Tolassi, Chiara
    Parigi, Marta
    Bertoli, Diego
    Mordenti, Cristina
    Galli, Alice
    Rizzardi, Andrea
    Caratozzolo, Salvatore
    Benussi, Alberto
    Ashton, Nicholas J.
    Blennow, Kaj
    Zetterberg, Henrik
    Giliani, Silvia
    Brugnoni, Duilio
    Padovani, Alessandro
    NEUROBIOLOGY OF AGING, 2024, 143 : 30 - 40
  • [5] Robustness of CSF Aβ42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes
    Leuzy, Antoine
    Mattsson-Carlgren, Niklas
    Cullen, Nicholas C.
    Stomrud, Erik
    Palmqvist, Sebastian
    La Joie, Renaud
    Iaccarino, Leonardo
    Zetterberg, Henrik
    Rabinovici, Gil
    Blennow, Kaj
    Janelidze, Shorena
    Hansson, Oskar
    ALZHEIMERS & DEMENTIA, 2023, 19 (07) : 2994 - 3004
  • [6] Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease
    Volker Welge
    Oliver Fiege
    Piotr Lewczuk
    Brit Mollenhauer
    Hermann Esselmann
    Hans-Wolfgang Klafki
    Stefanie Wolf
    Claudia Trenkwalder
    Markus Otto
    Johannes Kornhuber
    Jens Wiltfang
    Mirko Bibl
    Journal of Neural Transmission, 2009, 116 : 203 - 212
  • [7] Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer's disease
    Welge, Volker
    Fiege, Oliver
    Lewczuk, Piotr
    Mollenhauer, Brit
    Esselmann, Hermann
    Klafki, Hans-Wolfgang
    Wolf, Stefanie
    Trenkwalder, Claudia
    Otto, Markus
    Kornhuber, Johannes
    Wiltfang, Jens
    Bibl, Mirko
    JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (02) : 203 - 212
  • [8] The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's Dementia
    Santangelo, Roberto
    Dell'Edera, Alessandro
    Sala, Arianna
    Cecchetti, Giordano
    Masserini, Federico
    Caso, Francesca
    Pinto, Patrizia
    Leocani, Letizia
    Falautano, Monica
    Passerini, Gabriella
    Martinelli, Vittorio
    Comi, Giancarlo
    Perani, Daniela
    Magnani, Giuseppe
    CURRENT ALZHEIMER RESEARCH, 2019, 16 (07) : 587 - 595
  • [9] Relationship between baseline plasma p-tau181 and longitudinal changes in cognition and structural brain measures in a cohort of cognitively unimpaired older adults
    Pais, Marcos V.
    Kuo, Chia-Ling
    Ances, Beau M.
    Wetherell, Julie Loebach
    Lenze, Eric J.
    Diniz, Breno S.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (04)
  • [10] CSF Aβ1–42, but not p-Tau181, Predicted Progression from Amnestic MCI to Alzheimer’s Disease Dementia
    Liara Rizzi
    Luciane Missiaggia
    Matheus Roriz-Cruz
    NeuroMolecular Medicine, 2018, 20 : 491 - 497
12